Financials
Financial year 2025
Hematologie Ieper from Izegem, company number BE1028294624, closed financial year 2025 with a result of € 0 after tax. For that financial year Hematologie Ieper recorded a gross margin of € 729 and equity of € 1,000. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 26, 2026.
€ 1,000
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 15,267
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 40,702
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Hematologie Ieper?
What happened at Hematologie Ieper in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
- New establishment in Izegem. KBO
- ChiLi & Co became a director. NBB
- Start of the company according to the CBE. KBO
A new publication or filing at Hematologie Ieper? We notify you, reason included.
Follow Hematologie IeperDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of ChiLi & Co comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Hematologie IeperBehind Hematologie Ieper is ChiLi & Co. The shares are held by ChiLi & Co (100%).
Directors
According to the 2025 annual accounts
Director · represented by Chiel GHARAKHANI
since 2025
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Boomgaardstraat 11
8870 Izegem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1028.294.624
- VAT number
- BE 1028.294.624
- Registered office
- Boomgaardstraat 11, 8870 Izegem
- Names & denominations
- Hematologie Ieper
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 September 2025
- Peppol
- Active · Active since 22 Nov 2025
- Activities · NACE
Organisatie van congressen en beurzen
Overige vormen van onderwijs
Overige zakelijke dienstverlening, neg
Activiteiten van medisch specialisten